The sun imposes a 24‐h periodicity to life and circadian rhythms have evolved to maintain homoeostasis through the day/night cycle. In humans, there is a central clock that controls the sleep/wake cycle which is paralleled metabolically by a fast/feed cycle. The clock maintains homoeostasis by synchronising metabolism to the time of feeding. Loss of synchrony between the clock and hormonal rhythms results in loss of homoeostasis as evidenced by obesity, depression, and diabetes in people undertaking shift work. Cortisol has a distinct circadian rhythm; peaking on waking and low at sleep onset. Loss of this rhythm in adrenal insufficiency is associated with a poor quality of life and increased mortality. To replace the cortisol rhythm requires chronotherapy and for this you need to define the key parameters of the target rhythm, create a formulation to replicate that rhythm, and then prove clinical benefit. The physiology of hormones is more complex than that of nonnative drugs. Hormones are secreted with varied rhythms, bound to multiple cognate binding proteins, and actively transported and cleared through enzymatic pathways in multiple organs. We have examined the diurnal rhythm of cortisol in healthy volunteers, created physiologically‐based pharmacokinetic models, and tested various oral delayed and sustained formulations of hydrocortisone (development name, Chronocort) in clinical trials. The outcome from this work was the manufacture of modified‐release hydrocortisone hard capsules (tradename Efmody, Diurnal Ltd), that replicate the cortisol diurnal rhythm and improve the disease control of congenital adrenal hyperplasia the commonest hereditary form of adrenal insufficiency.
Developing oral chronotherapy for cortisol replacement in congenital adrenal hyperplasia
M. Whitaker,M. Debono,Richard J. Ross
Published 2023 in Clinical Endocrinology
ABSTRACT
PUBLICATION RECORD
- Publication year
2023
- Venue
Clinical Endocrinology
- Publication date
2023-09-28
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- Modified-release hydrocortisone hard capsules, marketed as Efmody, were manufactured to replicate the cortisol diurnal rhythm and improve disease control in congenital adrenal hyperplasia.박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review
CONCEPTS
- clinical trials
Human interventional studies used to test the hydrocortisone formulations described in the abstract.
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review - congenital adrenal hyperplasia
The hereditary adrenal disorder targeted by the replacement therapy described in the abstract.
Aliases: CAH
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review - cortisol diurnal rhythm
The daily pattern of cortisol secretion across the sleep-wake cycle discussed as the target rhythm for replacement therapy.
Aliases: cortisol rhythm
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review - efmody
The trade name for the modified-release hydrocortisone hard capsule product.
Aliases: Diurnal Ltd Efmody
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review - healthy volunteers
Human participants without the disease condition, used here to observe normal cortisol timing.
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review - hydrocortisone
The cortisol replacement hormone used in the formulations developed and tested in the program.
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review - modified-release hydrocortisone hard capsules
The final capsule formulation developed to provide modified release of hydrocortisone for cortisol replacement.
Aliases: hard capsules, modified-release capsules
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review - oral delayed and sustained formulations
Oral hydrocortisone dosage forms designed to release drug after a delay or over an extended period.
Aliases: delayed-release formulations, sustained-release formulations
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review - physiologically-based pharmacokinetic models
Mechanistic pharmacokinetic models that represent hormone handling using physiological processes and compartments.
Aliases: PBPK models
박진우 (dztg5apj7m) extraction뀨 (7c402c1b98) reviewB (s683577b42) reviewq (76h6bfydm6) reviewKiller Whale (322360f1c1) reviewAK (4715169a40) review
REFERENCES
Showing 1-38 of 38 references · Page 1 of 1
CITED BY
Showing 1-8 of 8 citing papers · Page 1 of 1